Header Logo

Connection

FERNANDO SCAGLIA to Oligopeptides

Back to Details
This is a "connection" page, showing publications FERNANDO SCAGLIA has written about Oligopeptides.
FERNANDO SCAGLIA
Connection Strength
0.204
Oligopeptides
  1. Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial. Orphanet J Rare Dis. 2024 Nov 21; 19(1):431.
    View in: PubMed
    Score: 0.204
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.